Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy.

[1]  F. Mitelman,et al.  Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients. , 2008, Hereditas.

[2]  M. Gonsebatt,et al.  Genotoxic effects of metronidazole. , 1996, Mutation research.

[3]  R. Sram,et al.  Genotoxicity and carcinogenicity of metronidazole. , 1994, Mutation research.

[4]  P. Ostrosky-Wegman,et al.  Metronidazole hprt mutation induction in sheep and the relationship with its elimination rate. , 1994, Mutation research.

[5]  A. Collins,et al.  Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. , 1993, Carcinogenesis.

[6]  M. Green,et al.  The single cell gel electrophoresis assay (comet assay): a European review. , 1993, Mutation research.

[7]  T. Lindahl.  Instability and decay of the primary structure of DNA , 1993, Nature.

[8]  S. Madle,et al.  General strategy for the assessment of genotoxicity. , 1991, Mutation research.

[9]  R. Knitza,et al.  DNA single strand-breaks in lymphocytes after metronidazole therapy. , 1991, Arzneimittel-Forschung.

[10]  E. Grzybowska,et al.  Lack of genotoxic activity of metronidazole and P1 derivative in two eukaryotic tests. , 1990, Polish journal of pharmacology and pharmacy.

[11]  S. Loft,et al.  Metronidazole and antipyrine as probes for the study of foreign compound metabolism. , 1990, Pharmacology & toxicology.

[12]  J. Jackson,et al.  Oxidant-induced DNA damage of target cells. , 1988, The Journal of clinical investigation.

[13]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[14]  D. Fleiszer,et al.  Effect of long-term metronidazole (MTZ) therapy on experimental colon cancer in rats. , 1984, The Journal of surgical research.

[15]  J. Lähdetie,et al.  Sperm abnormality assay of metronidazole and tinidazole. , 1984, Mutation research.

[16]  A. Amorosi,et al.  Induction of Lung Tumors and Lymphomas in BALB/c Mice by Metronidazole , 1983, Tumori.

[17]  J. Dayan,et al.  Mutagenic activity of 4 active-principle forms of pharmaceutical drugs. Comparative study in the Salmonella typhimurium microsome test, and the HGPRT and Na+/K+ ATPase systems in cultured mammalian cells. , 1982, Mutation research.

[18]  Mladen Korbelik,et al.  The mutagenicity of nitroaromatic drugs: effect of metronidazole after incubation in hypoxia in vitro. , 1980, Mutation research.

[19]  J. Prosser,et al.  The influence of two radiosensitizers on the induction of chromosome aberrations in human lymphocytes by X-radiation. , 1980, The British journal of radiology.

[20]  Wulf Hc.  Sister chromatid exchanges in lymphocytes treated with metronidazole. Preliminary communication. , 1980, Danish medical bulletin.

[21]  B. Hartley‐åsp.  Absence of chromosomal damage in the lymphocytes of patients treated with metronidazole for Trichomoniasis vaginalis , 1979 .

[22]  P. Olive.  Fertilizing or contaminating? , 1979, British Journal of Cancer.

[23]  U. Ringborg,et al.  Absence of genotoxic effects of metronidazole and two of its urinary metabolites on human lymphocytes in vitro. , 1979, Mutation research.

[24]  J. van der Stel,et al.  The mutagenic action of nitroimidazoles. IV. A comparison of the mutagenic action of several nitroimidazoles and some imidazoles. , 1979, Mutation research.

[25]  J. Swenberg,et al.  The evaluation of sixteen carcinogens in the rat using the micronucleus test. , 1978, Mutation research.

[26]  N. LaRusso,et al.  Interaction of metronidazole with nucleic acids in vitro. , 1977, Molecular pharmacology.

[27]  F. Mitelman,et al.  CHROMOSOME ABERRATIONS AND METRONIDAZOLE , 1976, The Lancet.

[28]  H. Rosenkranz,et al.  Mutagenicity of metronidazole: structure-activity relationships. , 1976, Mutation research.

[29]  Gardiner Pa.  Letter: care of children's eyes. , 1973 .

[30]  S. Cohen,et al.  Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes, and related compounds. , 1973, Journal of the National Cancer Institute.

[31]  P. Shubik,et al.  Induction of lung tumors and malignant lymphomas in mice by metronidazole. , 1972, Journal of the National Cancer Institute.

[32]  A. Collins,et al.  The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells. , 1995, Mutation research.

[33]  R. Knitza,et al.  Metronidazole induces DNA strand-breaks in cultures of human lymphocytes and phytohemagglutinin-stimulated human lymphocytes. , 1991, Arzneimittel-Forschung.

[34]  G. L. Kedderis,et al.  The metabolic activation of nitroheterocyclic therapeutic agents. , 1988, Drug metabolism reviews.

[35]  I. Rowland.  Factors affecting metabolic activity of the intestinal microflora. , 1988, Drug metabolism reviews.

[36]  M. Müller,et al.  Reductive activation of nitroimidazoles in anaerobic microorganisms. , 1986, Biochemical pharmacology.

[37]  D. Fleiszer,et al.  Increased incidence of experimental colon cancer associated with long-term metronidazole therapy. , 1983, American journal of surgery.

[38]  F. Roe.  Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. , 1983, Surgery.

[39]  G. Franke,et al.  Pharmacokinetics of Metronidazole in pregnant women. , 1981, Chemotherapy.

[40]  Andersson Ke.  Pharmacokinetics of nitroimidazoles. Spectrum of adverse reactions. , 1981 .

[41]  Smith Gh,et al.  Metronidazole in breast milk. , 1981 .

[42]  M. Müller.  Action of clinically utilized 5-nitroimidazoles on microorganisms. , 1981, Scandinavian journal of infectious diseases. Supplementum.

[43]  D. I. Edwards,et al.  The interaction of reduced metronidazole with DNA. , 1978, Biochemical pharmacology.